WHO WE ARE

HLB LifeScience
Difference Made Together

SEE THE STORY
  • HLB LifeScience Bio Business

    • Tegatrabeten (BC-2059)
      Tegatrabeten(BC-2059)介导淀粉样蛋白细胞中的 Wnt/β-catenin 信号通路
      癌症是阻断癌症的新机制。 β-catenin的低副作用和突变
      它是一种抗癌临床药物,对各种癌症有效,因为它是无关紧要的。
    • SP-2577
      SP-2577具有极高的生物利用度,不可逆转和高选择性
      赖氨酸特异性脱甲基酶1(LSD1)抑制剂用于各种癌症
      (前列腺癌,乳腺癌,小细胞肺癌,膀胱癌,神经母细胞瘤等)。
    • Core Technology
      Driving innovation across oncology,
      immunology, neuroscience and more.
    • Pipeline
      Advancing medicines with strong clinical
      performance in areas of great need.
    • Research Achievement
      Work with us to turn world-class research
      into life-changing results.